Maynard Um
-
-
-
-
-
-
-
Lucid Capital Markets Downgrades VistaGen Therapeutics (VTGN) to Neutral
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on VistaGen Therapeutics (VTGN)
-
-
-
-
-
397,240 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

